Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Conditions
Keywords
breast cancer, chemotherapy
Brief summary
Breast cancer is the most common malignant tumor among women. Side effects from initial chemotherapy include sleep disorders, anxiety, depression, and reduced quality of life. Mental health distress is also a major issue in cancer care. This study integrates mobile health information with a nurse-led communication support plan, aiming to improve patients' physical and mental outcomes during chemotherapy.
Detailed description
The objective of this study is to explore the effects of a nursing-led communication support program using mobile health information on physical and mental state in breast cancer patients undergoing initial chemotherapy.
Interventions
OTHERnursing-led communication support
nursing-led communication support program using mobile health information
OTHERNursing routine treatment
Nursing routine treatment
Sponsors
National Defense Medical Center, Taiwan
Study design
Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Caregiver, Outcomes Assessor)
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
breast cancer initial chemotherapy
Exclusion criteria
Patients whose cancer has recurred without undergoing the first course of chemotherapy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Quality of Life (EORTC QLQ-C30) | Baseline, 1 month, and 2 months after enrollment | Quality of life was measured using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30). Scores were transformed to a 0-100 scale according to the EORTC scoring manual. Higher scores indicate better functioning and global quality of life, whereas higher symptom scores indicate greater symptom burden. Measurements were obtained at baseline, 1 month, and 2 months after enrollment. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Anxiety and Depression | Baseline, 1 month, and 2 months after enrollment | Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS), a 14-item self-report questionnaire consisting of two 7-item subscales measuring anxiety (HADS-A) and depression (HADS-D). Each subscale is scored from 0 to 21, with higher scores indicating greater anxiety or depressive symptoms. |
Countries
Taiwan
Outcome results
None listed